Efficacy of Smartphone Based Digital Application in Improving Headache Related Parameters in Patients With Migraine
1 other identifier
interventional
400
1 country
1
Brief Summary
Migraine is a common headache disorder and affects 1 in 5 adults during their lifetime. It is a disorder which leads to significantly impaired quality of life, absence from work, loss of productivity in workplace and reduced vitality in social functioning. One of the important cornerstones in the management of migraine is the maintenance of a good headache diary. A headache diary enables the physician to understand the headache characteristics as well to establish the triggers causing the precipitation of episodes. The other important measure to ensure good outcomes is compliance to medications in those who have been prescribed prophylaxis. Migraine prophylaxis is by pills that have to be taken everyday at fixed time to ensure best outcomes. However, it is known that patients with migraine often are not adherent to prophylactic medications. A meta-analysis of 33 studies found that observational studies (n = 14) showed adherence ranging from 41% to 95% at 2 months after initiation of medication and 21% to 80% at 6 months. Pooled rates of persistence derived from 19 RCTs on propranolol, amitriptyline, and topiramate showed adherence rates of 77%, 55%, and 57%, respectively, at 16-26 weeks of initiation. The real world adherence is expected to be lower than that in the ideal settings of randomized trials. Regular pill reminders issued through smartphone based applications can improve medication adherence and thus improve headache outcomes. Though smartphone based migraine tracker digital applications are available, they mostly are aimed at capturing headache characteristics. The efficacy of providing pill reminders along with patient educational materials and community blog to enable migraineurs share their experiences with each other has not been studied in controlled trials. It is known that patients who are well informed about their chronic diseases such as migraine often have better outcomes. Busy clinicians often resort to providing pamphlets regarding the disease, triggers, acute pain relief medications, prophylactic therapy etc. However, it is yet to be studied if a digital application with all these inbuilt features, which are easily accessible at the finger tips would lead to better information uptake and improved compliance and self management. This RCT would try to assess this gap in knowledge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2021
CompletedStudy Start
First participant enrolled
July 25, 2021
CompletedFirst Posted
Study publicly available on registry
July 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2023
CompletedJuly 30, 2021
July 1, 2021
1.4 years
July 18, 2021
July 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in HIT-6 (Headache impact test-6) score
To compare the change in HIT-6 (Headache impact test-6 ranges from 36-78 with a higher score indicating greater severity) score from baseline to 4 weeks after introduction of the digital smartphone based application vs paper-pen diary.
4 weeks
Reduction in headache days
To compare the percentage of patients reporting 30 % or more reduction in headache days at 4 weeks following introduction of digital smart phone based application vs paper-pen diary .
4 weeks
Secondary Outcomes (11)
Compliance
4 weeks
Number of headache days per 28 days
4 weeks
Change in number of headache days per 28 days from baseline
4 weeks
change from baseline in the number of days with severe headaches per 28 days
4 weeks
Change from baseline in the duration of headache episodes in the preceding 4 weeks
4 weeks
- +6 more secondary outcomes
Study Arms (2)
Smart phone based digital app arm
EXPERIMENTALDigital smartphone application which tracks migraine and to offers pill reminders for medication adherence and community blog and disease related educational material for migraineurs will be given to the patients
Paper and pen diary arm
ACTIVE COMPARATORClinic based education and traditional paper-pen diary will be administered in tracking headache parameters
Interventions
Smartphone Based Digital Application to Track Migraine, Offer Pill Reminders for Medication Adherence and Community Blog
Eligibility Criteria
You may qualify if:
- Adult patients attending neurology OPD.
- At least 18 years of age; any gender.
- Episodic or chronic migraine diagnosed (using International Classification of Headache Disorders-3 (ICHD-3) .
- No modifications to the prophylactic therapy or acute pain relief medications is planned over the next 3 months.
- Can read and write in Hindi or English easily.
- Have an Android/iOS smart phone in which digital application can be installed and who knows how to operate smart phone.
- Ready to provide consent and willing to adhere to protocol and comply with follow up visits.
- No major neurological or systemic medical condition that reduces life expectancy to less than 1 year based on clinical prediction scores.
You may not qualify if:
- Not willing to adhere to protocol.
- Not willing to provide consent.
- Inability or unwillingness to complete diary recording.
- Patients with Medication over use headache ( as per ICHD -3).
- Other primary headaches and secondary headache disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
All India Institute of Medical Sciences, New Delhi
New Delhi, National Capital Territory of Delhi, 110029, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The participant, investigator and care provider will be aware of the intervention and the sequence in which it is administered. The outcomes will be assessed by an outcome assessor who will not be aware of the arm into which the participant was randomized prior to the assessment.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Department of Neurology
Study Record Dates
First Submitted
July 18, 2021
First Posted
July 30, 2021
Study Start
July 25, 2021
Primary Completion
December 31, 2022
Study Completion
January 31, 2023
Last Updated
July 30, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- will be available within 6 weeks for as long as suggested by our institute ethics committee
- Access Criteria
- Request to be made through the Institute ethics committee and would be processed as per Institute rules
On reasonable request from the investigator through our AIIMS Institute ethics committee, the individual participant data will be made available to other researchers